55899-41-7 Usage
Uses
Used in Pharmaceutical Industry:
Pyrazolo[1,5-a]pyridine-4-carboxylic acid is utilized as a key intermediate in the synthesis of pharmaceuticals for the treatment of various diseases. Its unique structure and functional groups make it a valuable component in the development of novel drug candidates.
Used in Organic Synthesis:
In the field of organic synthesis, pyrazolo[1,5-a]pyridine-4-carboxylic acid serves as a building block for the creation of more complex organic molecules. Its heterocyclic structure and carboxylic acid functionality provide a versatile platform for further chemical modifications and the synthesis of diverse organic compounds.
Ongoing Research:
The scientific community continues to explore the properties and potential applications of pyrazolo[1,5-a]pyridine-4-carboxylic acid. Further research is being conducted to better understand its role in pharmaceutical development, organic synthesis, and other possible applications, with the aim of harnessing its full potential in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 55899-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,9 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 55899-41:
(7*5)+(6*5)+(5*8)+(4*9)+(3*9)+(2*4)+(1*1)=177
177 % 10 = 7
So 55899-41-7 is a valid CAS Registry Number.
55899-41-7Relevant academic research and scientific papers
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
-
, (2008/06/13)
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Interactive SAR studies: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists
Bettinetti, Laura,Schlotter, Karin,Hübner, Harald,Gmeiner, Peter
, p. 4594 - 4597 (2007/10/03)
Starting from dopamine receptor ligand BP897, an interactive drug discovery process leading to heterocyclic bioisosteres is demonstrated. The four step strategy involved a careful optimization of geometric and electronic properties by systematic modificat
